• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical trial report: Eradication of Helicobacter pylori reduces the risk for subsequent gastric cancer.

作者信息

Pisegna Joseph R, Surti Bijal, Scott David R

机构信息

CURE: Digestive Diseases Research Center, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.

出版信息

Curr Gastroenterol Rep. 2010 Dec;12(6):427-30. doi: 10.1007/s11894-010-0138-8.

DOI:10.1007/s11894-010-0138-8
PMID:20857239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2974208/
Abstract
摘要

相似文献

1
Clinical trial report: Eradication of Helicobacter pylori reduces the risk for subsequent gastric cancer.临床试验报告：根除幽门螺杆菌可降低后续患胃癌的风险。
Curr Gastroenterol Rep. 2010 Dec;12(6):427-30. doi: 10.1007/s11894-010-0138-8.
2
Effect of Helicobacter pylori eradication on subsequent dysplasia development after endoscopic resection of gastric dysplasia.幽门螺杆菌根除对胃发育异常内镜切除术后后续发育异常发生的影响。
Korean J Gastroenterol. 2013 Jun;61(6):307-12. doi: 10.4166/kjg.2013.61.6.307.
3
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.在中国高危地区根除幽门螺杆菌预防胃癌：一项随机对照试验。
JAMA. 2004 Jan 14;291(2):187-94. doi: 10.1001/jama.291.2.187.
4
Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial.根除幽门螺杆菌预防胃癌的作用：一项随机对照试验。
Gastrointest Endosc. 2018 Sep;88(3):475-485.e2. doi: 10.1016/j.gie.2018.05.009. Epub 2018 May 22.
5
Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer.根除幽门螺杆菌预防早期胃癌内镜切除术后异时性复发
J Korean Med Sci. 2015 Jun;30(6):749-56. doi: 10.3346/jkms.2015.30.6.749. Epub 2015 May 13.
6
Endoscopic gastric atrophy is strongly associated with gastric cancer development after Helicobacter pylori eradication.内镜下胃萎缩与幽门螺杆菌根除后胃癌的发生密切相关。
Surg Endosc. 2017 May;31(5):2140-2148. doi: 10.1007/s00464-016-5211-4. Epub 2016 Sep 7.
7
Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer.早期胃癌内镜切除后，幽门螺杆菌根除对异时性胃癌发展的长期影响。
Gastrointest Endosc. 2012 Jan;75(1):39-46. doi: 10.1016/j.gie.2011.08.030. Epub 2011 Oct 21.
8
Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model.幽门螺杆菌根除治疗预防胃癌的成本效益分析：一个马尔可夫模型。
Dig Dis Sci. 2020 Jun;65(6):1679-1688. doi: 10.1007/s10620-019-05910-1. Epub 2019 Oct 30.
9
Risk Factors for Gastric Cancer after the Eradication of Helicobacter pylori Evaluated Based on the Background Gastric Mucosa: A Propensity Score-matched Case-control Study.基于背景胃黏膜评估幽门螺杆菌根除后胃癌的危险因素：一项倾向评分匹配的病例对照研究。
Intern Med. 2021 Apr 1;60(7):969-976. doi: 10.2169/internalmedicine.5486-20. Epub 2020 Nov 9.
10
eradication therapy to prevent gastric cancer: systematic review and meta-analysis.根除疗法预防胃癌：系统评价和荟萃分析。
Gut. 2020 Dec;69(12):2113-2121. doi: 10.1136/gutjnl-2020-320839. Epub 2020 Mar 23.

引用本文的文献

1
Advances in the Aetiology & Endoscopic Detection and Management of Early Gastric Cancer.早期胃癌的病因学、内镜检测及管理进展
Cancers (Basel). 2021 Dec 13;13(24):6242. doi: 10.3390/cancers13246242.

本文引用的文献

1
Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers.幽门螺杆菌感染与食管癌风险降低相关，且不受环境和遗传修饰因素的影响。
Gastroenterology. 2010 Jul;139(1):73-83; quiz e11-2. doi: 10.1053/j.gastro.2010.04.009. Epub 2010 Apr 14.
2
Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.早期根除幽门螺杆菌可降低消化性溃疡病患者患胃癌的风险。
Gastroenterology. 2009 Nov;137(5):1641-8.e1-2. doi: 10.1053/j.gastro.2009.07.060. Epub 2009 Aug 5.
3
Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods.12年间幽门螺杆菌对6种抗菌药物的耐药率及演变情况与药敏试验方法之间的相关性
Diagn Microbiol Infect Dis. 2008 Apr;60(4):409-15. doi: 10.1016/j.diagmicrobio.2007.11.008. Epub 2008 Jan 14.
4
Helicobacter pylori and antibiotic resistance.幽门螺杆菌与抗生素耐药性。
Gut. 2007 Nov;56(11):1502. doi: 10.1136/gut.2007.132514.
5
American College of Gastroenterology guideline on the management of Helicobacter pylori infection.美国胃肠病学会幽门螺杆菌感染管理指南
Am J Gastroenterol. 2007 Aug;102(8):1808-25. doi: 10.1111/j.1572-0241.2007.01393.x. Epub 2007 Jun 29.
6
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.幽门螺杆菌感染管理的当前概念：马斯特里赫特III共识报告。
Gut. 2007 Jun;56(6):772-81. doi: 10.1136/gut.2006.101634. Epub 2006 Dec 14.
7
The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis.CYP2C19基因多态性对质子泵抑制剂一线双联和三联疗法中幽门螺杆菌根除率的影响：一项荟萃分析
Am J Gastroenterol. 2006 Jul;101(7):1467-75. doi: 10.1111/j.1572-0241.2006.00717.x.
8
Helicobacter pylori persistence: biology and disease.幽门螺杆菌的持续存在：生物学与疾病
J Clin Invest. 2004 Feb;113(3):321-33. doi: 10.1172/JCI20925.
9
Helicobacter pylori infection and the development of gastric cancer.幽门螺杆菌感染与胃癌的发生
N Engl J Med. 2001 Sep 13;345(11):784-9. doi: 10.1056/NEJMoa001999.
10
Risk for gastric cancer after antibiotic prophylaxis in patients undergoing hip replacement.
Cancer Res. 2000 Nov 15;60(22):6376-80.